13F filerCIK 1061768 ↗
Baupost Group
You are looking at Q4 2018. See the latest, Q3 2026 →
Reported value
$11.52B
−12% on the quarter before
Positions
37
6 new, 7 sold out
Top 10
72.7%
of the value
Est. gain
−$1.89B
on stocks held all quarter
Est. return
−16.5%
on those stocks since Q3 2018
Positions as of Dec 31, 2018, from Baupost Group's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q3 2018. Striped tiles are options.
Largest buys
Since Q3 2018, sized at quarter-end prices.
- Ebay Inc~$589.5MNew, 0.0% → 5.1% of the portfolio+21,000,000 shares
- Liberty Global Plc~$391.6MAdded, 2.3% → 5.3% of the portfolio+18,973,925 shares
- Univar Inc~$137.1MAdded, 0.4% → 1.5% of the portfolio+7,728,900 shares
- Akebia Therapeutics Inc~$135.3MNew, 0.0% → 1.2% of the portfolio+24,471,453 shares
- Cbs Corp New~$111.4MNew, 0.0% → 1.0% of the portfolio+2,547,059 shares
- Nexstar Media Group Inc~$74.7MNew, 0.0% → 0.6% of the portfolio+950,000 shares
- Pioneer Nat Res Co~$65.8MAdded, 5.3% → 5.1% of the portfolio+500,000 shares
- Shire Plc~$62.9MAdded, 0.1% → 0.7% of the portfolio+361,541 shares
- Antero Res Corp~$18.8MAdded, 3.6% → 2.3% of the portfolio+2,000,000 shares
- Sentinel Energy Svcs Inc~$16.5MNew, 0.0% → 0.1% of the portfolio+1,600,000 shares
Largest sells
Since Q3 2018, sized at quarter-end prices.
- Tribune Media Co~$230.4MSold out, 1.8% → 0.0% of the portfolio−5,996,042 shares
- Altaba Inc~$191.5MSold out, 1.5% → 0.0% of the portfolio−2,810,775 shares
- Cardinal Health Inc~$145.9MCut, 2.0% → 0.6% of the portfolio−3,270,833 shares
- Keryx Biopharmaceuticals Inc~$87.7MSold out, 0.7% → 0.0% of the portfolio−25,791,678 shares
- Pg&E Corp~$83.3MCut, 6.7% → 3.2% of the portfolio−3,505,307 shares
- Amerisourcebergen Corp~$54.8MCut, 1.9% → 1.3% of the portfolio−736,757 shares
- Mckesson Corp~$50.3MCut, 2.2% → 1.6% of the portfolio−455,689 shares
- Novagold Res Inc~$50.0MSold out, 0.4% → 0.0% of the portfolio−13,467,145 shares
- Gty Technology Holdings Inc~$47.6MSold out, 0.4% → 0.0% of the portfolio−4,400,000 shares
- Synchrony Finl~$41.7MCut, 3.9% → 3.0% of the portfolio−1,779,372 shares
Holdings
As of Dec 31, 2018; changes in shares since Sep 30, 2018.
| Holding | Value | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Twenty First Centy Fox IncCL A · shares −1.4% · price +3.9% | 21.4% | $2.47B | +$91.8M | ||||||
| Cheniere Energy IncCOM NEW · shares 0% · price −14.8% | 7.3% | $840.3M | −$146.2M | ||||||
| Twenty First Centy Fox IncCL B · shares −1.6% · price +4.3% | 7.1% | $814.2M | +$33.4M | ||||||
| Viasat IncCOM · shares 0% · price −7.8% | 7.0% | $809.5M | −$68.7M | ||||||
| QorvoCOM · shares −2.9% · price −21.0% | 5.6% | $648.7M | −$172.6M | ||||||
| Allergan PlcSHS · shares −3.9% · price −29.8% | 5.5% | $635.6M | −$270.2M | ||||||
| Liberty Global PlcSHS CL C · shares +176% · price −26.7% | 5.3% | $613.9M | −$81.0M | ||||||
| Pioneer Nat Res CoCOM · shares +13% · price −24.5% | 5.1% | $591.8M | −$170.7M | ||||||
| Ebay IncCOM · shares New | 5.1% | $589.5M | — | ||||||
| Pg&E CorpCOM · shares −18% · price −48.4% | 3.2% | $367.5M | −$344.5M | ||||||
| TeslaNOTE 2.375% 3/1 · shares 0% · price +18.0% | 3.2% | $364.1M | — | ||||||
| Synchrony FinlCOM · shares −11% · price −24.5% | 3.0% | $341.4M | −$110.9M | ||||||
| Antero Res CorpCOM · shares +7.5% · price −47.0% | 2.3% | $268.4M | −$221.2M | ||||||
| Theravance Biopharma IncCOM · shares 0% · price −21.7% | 2.1% | $238.2M | −$65.9M | ||||||
| Colony Cap Inc NewCL A COM · shares 0% · price −23.2% | 2.0% | $232.5M | −$70.1M | ||||||
| Atara Biotherapeutics IncCOM · shares 0% · price −16.0% | 1.9% | $217.3M | −$41.3M | ||||||
| Mckesson CorpCOM · shares −21% · price −16.7% | 1.6% | $190.0M | −$38.1M | ||||||
| Univar IncCOM · shares +436% · price −42.1% | 1.5% | $168.5M | −$22.9M | ||||||
| Amerisourcebergen CorpCOM · shares −27% · price −19.3% | 1.3% | $149.9M | −$35.9M | ||||||
| Akebia Therapeutics IncCOM · shares New | 1.2% | $135.3M | — | ||||||
| Cbs Corp NewCL B · shares New | 0.97% | $111.4M | — | ||||||
| Liberty Global PlcSHS CL A · shares 0% · price −26.2% | 0.92% | $105.8M | −$37.6M | ||||||
| Veritiv CorpCOM · shares 0% · price −31.4% | 0.77% | $89.0M | −$40.7M | ||||||
| Ypf Sociedad AnonimaSPON ADR CL D · shares 0% · price −13.3% | 0.70% | $80.3M | −$12.4M | ||||||
| Shire PlcSPONSORED ADR · shares +365% · price −4.0% | 0.70% | $80.1M | −$714,815 | ||||||
| Total 37 positions | 100% | $11.52B | −$1.89B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2018 to Q4 2018: 29 stocks held throughout, down $1.89B (−16.5%).
- Twenty First Centy Fox Inc+$91.8M+4%
- Twenty First Centy Fox Inc+$33.4M+4%
- Nexeo Solutions Inc3:1 split+$491,000+17%
- Pioneer Nat Res Co−$170.7M−24%
- Qorvo−$172.6M−21%
- Antero Res Corp−$221.2M−47%
- Allergan Plc−$270.2M−30%
- Pg&E Corp−$344.5M−48%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Nov 13, 2026 | $5.05B−7% | SEC ↗ |
| Q2 2026 | Aug 13, 2026 | $5.42B+6% | SEC ↗ |
| Q1 2026 | May 14, 2026 | $5.12B−3% | SEC ↗ |
| Q4 2025 | Feb 13, 2026 | $5.28B+10% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $4.79B+16% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $4.13B+18% | SEC ↗ |
| Q1 2025 | May 14, 2025 | $3.50B+2% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $3.43B−2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $3.52B−3% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $3.63B−0% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $3.65B−20% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $4.59B−12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $5.21B−7% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $5.61B−4% | SEC ↗ |
| Q1 2023 | May 12, 2023 | $5.85B−5% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $6.13B+6% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $5.79B−14% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $6.77B−27% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $9.30B−8% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $10.13B−7% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $10.88B−12% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $12.33B−2% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $12.56B+16% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $10.84B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $9.25B+15% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $8.01B+18% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $6.77B−25% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $9.06B+3% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $8.83B−20% | SEC ↗ |
| Q2 2019 | Aug 13, 2019 | $11.05B−7% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $11.90B+3% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 | $11.52B−12% | SEC ↗ |
| Q3 2018 | Nov 15, 2018 (amended) | $13.06B+14% | SEC ↗ |
| Q2 2018 | Aug 13, 2018 | $11.44B+10% | SEC ↗ |
| Q1 2018 | May 14, 2018 | $10.37B+3% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $10.11B+26% | SEC ↗ |
| Q3 2017 | Nov 13, 2017 | $8.02B−8% | SEC ↗ |
| Q2 2017 | Aug 11, 2017 | $8.75B+3% | SEC ↗ |
| Q1 2017 | May 25, 2017 (amended) | $8.49B+11% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $7.67B+9% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $7.04B−4% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $7.37B+6% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $6.92B | SEC ↗ |